Role of APPs in the Delivery of Anti-Amyloid Therapies

EP: 1.Burden of Alzheimer Disease and Key Stakeholders Involved in Care

EP: 2.Role of APPs in Alzheimer Disease Care in Community and Academic Settings

EP: 3.Strategies for Early Detection in Alzheimer Disease

EP: 4.Impact of Timely Alzheimer Diagnosis on Treatment Selection and Disease Progression

EP: 5.Operational Challenges With Early Identification in Alzheimer Disease

EP: 6.Opportunities for APPs to Lead Early Alzheimer Disease Care

EP: 7.Treatment Options in Alzheimer Disease

EP: 8.Strategies for Identifying Eligible Candidates for Anti-Amyloid Therapies

Now Viewing

EP: 9.Role of APPs in the Delivery of Anti-Amyloid Therapies

EP: 10.Navigating Alzheimer Disease Treatment Decisions and Timelines

Panelists discuss how advanced practice providers (APPs) coordinate the logistical aspects of anti-amyloid therapy delivery, including imaging, infusion scheduling, and follow-up visits. Their organizational role ensures smooth transitions and minimizes patient disruption.

Panelists discuss how effective monitoring protocols—covering infusion reactions, laboratory testing, and symptom tracking—are essential for patient safety. APPs’ consistent communication with patients fosters adherence and early issue detection.

Panelists discuss how this coordination enhances system efficiency and strengthens patient confidence in complex treatment regimens. The segment highlights APPs as operational anchors within multidisciplinary teams delivering cutting-edge Alzheimer care.